Innoval-Hc

The Institute for Innovation & Valuation in Health Care, InnoVal-HC, is an independent not-for-profit research organization. It was established by scientists with medical, health economic, and econometric backgrounds, as well as hands-on management experience, to analyze the economic dimension of health and health care, including research into the normative foundations and the methods of health economics, applied cost of illness and cost benefit studies, and their use in Health Technology Assessment (HTA). Major areas of interest extend beyond traditional cost effectiveness and cost benefit analyses, encompassing both the normative foundations and the methods of health economic evaluations, Health Technology Assessments (HTAs) in theory and practice, health care utilization and cost studies (including socioeconomic burden studies from the patients' perspective and budget impact analyses), as well as the identification, demonstration, measurement and communication of the clinical and economic value of “health technologies”, including the related issues of market access, pricing and reimbursement (for example, for diagnostics, medical devices, pharmaceutical products, and likewise institutional arrangements and processes of health care delivery). Members of the Institute have been involved in teaching econometrics, statistics, health economics, medical and managerial decision analysis, and innovation and change management courses in academic settings as well in executive education programs, at institutions such as the London School of Economics (LSE), the European Market Access University Diploma (EMAUD) program at the University Claude Bernard Lyon I (UCBL I), the Frankfurt School of Finance & Management (FSFM), and the Universities of Heidelberg, Mannheim, Heilbronn, and Ludwigshafen.